N4-Substituted Piperazinyl Norfloxacin Derivatives with Broad-Spectrum Activity and Multiple Mechanisms on Gyrase, Topoisomerase IV, and Bacterial Cell Wall Synthesis
Journal article, 2023

Fluoroquinolones are an important class of antibiotics with broad-spectrum antibacterial and antitubercular activity. Here, we describe the design and synthesis of a series of 38 N4-substituted piperazinyl norfloxacin derivatives. Their activity and mechanism of action were characterized using in silico, in vitro, and in vivo approaches. Several compounds displayed interesting activities against both Gram-negative and Gram-positive bacteria, and few displayed antimycobacterial activity, whereby some were as potent as norfloxacin and ciprofloxacin. Molecular docking experiments suggested that the new derivatives inhibit both DNA gyrase and DNA topoisomerase IV in a similar manner as norfloxacin. Selecting the most promising candidates for experimental mode of action analysis, we confirmed DNA gyrase and topoisomerase IV as targets of all tested compounds using enzymatic in vitro assays. Phenotypic analysis of both Escherichia coli and Bacillus subtilis confirmed a typical gyrase inhibition phenotype for all of the tested compounds. Assessment of possible additional targets revealed three compounds with unique effects on the B. subtilis cell wall synthesis machinery, suggesting that they may have an additional target in this pathway. Comparison with known cell wall synthesis inhibitors showed that the new compounds elicit a distinct and, so far, unique phenotype, suggesting that they act differently from known cell wall synthesis inhibitors. Interestingly, our phenotypic analysis revealed that both norfloxacin and ciprofloxacin displayed additional cellular effects as well, which may be indicative of the so far unknown additional mechanisms of fluoroquinolones.

fluoroquinolones

molecular docking

multidrug resistance

norfloxacin

cell wall synthesis

bacterial cytological profiling

Author

Ahmed M. Kamal El-Sagheir

Assiut University

Ireny Abdelmesseh Nekhala Abdelmesseh

Chalmers, Life Sciences, Chemical Biology

Mohammed K. Abd El-Gaber

Assiut University

Ahmed S. Aboraia

Assiut University

Jonatan Persson

CARe

Chalmers, Life Sciences, Chemical Biology

Ann-Britt Schäfer

Chalmers, Life Sciences, Chemical Biology

CARe

Michaela Wenzel

Chalmers, Life Sciences, Chemical Biology

CARe

Farghaly A. Omar

Assiut University

ACS Bio and Med Chem Au

26942437 (eISSN)

Vol. 3 6 494-506

Interaction of antibiotics with bacterial cells

Chalmers, 2024-01-01 -- 2026-12-31.

Chalmers, 2019-09-02 -- 2023-08-31.

Subject Categories

Biochemistry and Molecular Biology

Medicinal Chemistry

Microbiology in the medical area

DOI

10.1021/acsbiomedchemau.3c00038

More information

Latest update

12/7/2024